Filing Details

Accession Number:
0000769993-19-000269
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-04 09:08:02
Reporting Period:
2019-04-01
Accepted Time:
2019-04-04 09:08:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1496268 Reva Medical Inc. RVA:AX Security Brokers, Dealers & Flotation Companies (6211) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
886982 Goldman Sachs Group Inc 200 West Street
New York NY 10282
No No No No
908777 International Sachs Goldman Peterborough Court
133 Fleet Street
London EC4A 2BB
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Disposition 2019-04-01 2,444,695 $0.00 1,930,305 No 4 S Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnotes
Footnotes
  1. This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group") and Goldman Sachs International ("GSI" and, together with GS Group, the "Reporting Persons"). GSI is a wholly-owned subsidiary of GS Group. The Reporting Persons disclaim beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein, if any.
  2. Sale of 24,446,956 CHESS Depositary Interests("CDIs") to the Issuer at a price of $0.000004 per CDI. Ten CDIs are equivalent to one share of common stock of the Issuer, par value $0.0001 per share (the "Common Stock").
  3. GS Group may be deemed to beneficially own indirectly 1,930,305 shares of Common Stock by reason of GSI's direct beneficial ownership of the Common Stock.